Ehud Marom
Founder, Chairman & CEO
Your CSV is on the way
We’ve sent your CSV file to email@email.com
Claimed by
owner Add to list
Mapi Pharma
Former names:
Lifecycle Management for Pharmaceuticals
Stealth Mode
Mapi Pharma
Mapi Pharma Overview
Mapi Pharma is a clinical-stage pharmaceutical company developing proprietary pharmaceuticals, including lifecycle management products such as Depot long-acting injections, complex active pharmaceutical ingredients, and formulations.
The company’s lead product is Glatiramer Acetate Depot, a once-monthly injection for the treatment of patients with multiple sclerosis. Mapi is also engaged in the development of Pregabalin ER for the treatment of neuropathic pain and epilepsy, Paliperidone Palmitate and Buspirone ER for the treatment of schizophrenia, and other long-acting Depot injectable treatments.
The company’s lead product is Glatiramer Acetate Depot, a once-monthly injection for the treatment of patients with multiple sclerosis. Mapi is also engaged in the development of Pregabalin ER for the treatment of neuropathic pain and epilepsy, Paliperidone Palmitate and Buspirone ER for the treatment of schizophrenia, and other long-acting Depot injectable treatments.
Cumulative Funding Raised Over Time ($)
Employees Over Time
Mapi Pharma Climate Tech relevance
null
No Data, yet.
Sorry, no content found under this section.
Oct 12, 2022
www.globenewswire.com
Mapi Pharma to Host a Key Opinion Leader Webinar on Glatiramer Acetate Depot
#Customers
Sep 21, 2022
www.globenewswire.com
Mapi Pharma Announces Positive Top-Line Results from GA Depot Phase III Trial for Relapsing forms of Multiple Sclerosis (RMS)
#Customers
May 31, 2022
www.globenewswire.com
Mapi Pharma to Present Late Breaking Poster Presentation on GA Depot for Treating Primary Progressive Forms of Multiple Sclerosis at CMSC 2022 Annual Meeting
#Partners #Investment
Mar 30, 2022
www.globenewswire.com
Mapi Pharma Receives U.S. Patent Covering Methods of Suppressing or Alleviating Primary or Secondary Progressive Multiple Sclerosis with a Sustained Release Glatiramer Acetate Depot
#Partners #Investment
Oct 21, 2021
www.globenewswire.com
Mapi Pharma Signs Agreement with Gaelan Medical Trade LLC to Exclusively Market and Distribute Mapi Products in UAE
#Partners
Companies you might be interested in
Driven by Finder AI
-
Concenter BioPharmaDrugs for the Treatment and Prevention of Type 2 Diabetes1-10 employees • Funding Stage: A
shared sectors
Also shared
Are these companies similar? -
TenAces BiosciencesMolecular Glue Therapeutics1-10 employees • Funding Stage: Seed
shared sectors
Also shared
Are these companies similar? -
DenovAI BiotechDynamic Protein Design11-50 employees • Funding Stage: Seed
shared sectors
Also shared
Are these companies similar? -
ImPact BiotechTargeted Treatment for Selective Tumor Ablation11-50 employees • Funding Stage: Pre-Funding
shared sectors
Also shared
Are these companies similar?
Primary sector
Total funding
Funding stage
Number of employees
Founded
Related Content
Lists. Maps. Reports
Team Members
EM
UD
AM
NB
SR
Contact Team
Affiliated Organizations
(null)Web & social links
https://mapi-pharma.com
Locations
Israel
Einstein Street 16, Ness Ziona, Israel
Offices Abroad
Nanjing, Jiangsu, China
Photos & videos
(1)No Data, yet.
Sorry, no content found under this section.
Injection Guidelines: GA Depot and GA Depot Placebo- HEBREW Subtitles
Mapi Pharma Business
Sector
Primary:
Health Tech & Life Sciences
Target Customer
Core Technology
Use Cases
(0)Tech Community Involvement
(0)Mapi Pharma Financials
Cumulative Funding Raised Over Time ($)
No Data, yet.
Sorry, no content found under this section.
Public Offerings & Exits
Private Equity Funding
Non-Equity Funding
Mergers and Acquisitions
Mapi Pharma Lifecycle
Cumulative Funding Raised Over Time ($)
Timeline
Employees Over Time
News Over Time
No Data, yet.
Sorry, no content found under this section.
Mapi Pharma News
News Over Time
No Data, yet.
Sorry, no content found under this section.
News Articles
Oct 12, 2022
www.globenewswire.com
Mapi Pharma to Host a Key Opinion Leader Webinar on Glatiramer Acetate Depot
#Customers
Sep 21, 2022
www.globenewswire.com
Mapi Pharma Announces Positive Top-Line Results from GA Depot Phase III Trial for Relapsing forms of Multiple Sclerosis (RMS)
#Customers
May 31, 2022
www.globenewswire.com
Mapi Pharma to Present Late Breaking Poster Presentation on GA Depot for Treating Primary Progressive Forms of Multiple Sclerosis at CMSC 2022 Annual Meeting
#Partners #Investment
Mar 30, 2022
www.globenewswire.com
Mapi Pharma Receives U.S. Patent Covering Methods of Suppressing or Alleviating Primary or Secondary Progressive Multiple Sclerosis with a Sustained Release Glatiramer Acetate Depot
#Partners #Investment
Oct 21, 2021
www.globenewswire.com
Mapi Pharma Signs Agreement with Gaelan Medical Trade LLC to Exclusively Market and Distribute Mapi Products in UAE
#Partners
Related Content
Mapi Pharma Team
No Data, yet.
Sorry, no content found under this section.
Employees Over Time
Companies you might be interested in
Driven by Finder AI
-
Concenter BioPharmaDrugs for the Treatment and Prevention of Type 2 Diabetes1-10 employees • Funding Stage: A
shared sectors
Also shared
Are these companies similar? -
TenAces BiosciencesMolecular Glue Therapeutics1-10 employees • Funding Stage: Seed
shared sectors
Also shared
Are these companies similar? -
DenovAI BiotechDynamic Protein Design11-50 employees • Funding Stage: Seed
shared sectors
Also shared
Are these companies similar? -
ImPact BiotechTargeted Treatment for Selective Tumor Ablation11-50 employees • Funding Stage: Pre-Funding
shared sectors
Also shared
Are these companies similar?
Mapi Pharma Internal
Create note
Notes
(undefined)
Filter notes
Content Writer
undefined
BI Verification
undefined
Phone Number
undefined
Israel Register ID
undefined
Confidence Score
undefined
Missing Fields
undefined
Profile Creator
undefined
Profile Update
undefined
undefined
Access Comprehensive Financial Analytics
Create a free account to:
- Explore detailed financial analytics.
- Track company growth and size.
- Connect with company team members.
I already have access,
I already have access,